Calamos Advisors’s Compugen CGEN Stock Holding History

Calamos Advisors’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-29,500	Closed	-$62.8K	–	1028
2026 Q1	$62.8K	Buy	+29,500	New	+$57.3K	﹤0.01%	1143

Other funds holding CGEN

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Atom Investors Austin, Texas $1.12B AUM 38.14% 1-Year Est. Return

Calamos Advisors's CGEN Position: Q2 2026 in Review

Calamos Advisors sold out of Compugen (CGEN) in Q2 2026, closing a stake of 29,500 shares — an estimated $62.8K sold.

Calamos Advisors first reported a position in CGEN in Q1 2026 and held it in 1 quarter. The position peaked at $62.8K in Q1 2026. 82 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.

Calamos Advisors reported no remaining Compugen position as of Q2 2026 after selling out during the quarter.
Calamos Advisors sold 29,500 Compugen shares in Q2 2026, an estimated $62.8K.
Calamos Advisors first reported a position in Compugen in Q1 2026 and held it in 1 quarter.
Calamos Advisors's Compugen position peaked at $62.8K in Q1 2026.
82 funds tracked by Wall St. Rank held Compugen as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.